These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 33918105)
1. Flecainide How and When: A Practical Guide in Supraventricular Arrhythmias. Lavalle C; Magnocavallo M; Straito M; Santini L; Forleo GB; Grimaldi M; Badagliacca R; Lanata L; Ricci RP J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33918105 [TBL] [Abstract][Full Text] [Related]
2. Flecainide in Ventricular Arrhythmias: From Old Myths to New Perspectives. Lavalle C; Trivigno S; Vetta G; Magnocavallo M; Mariani MV; Santini L; Forleo GB; Grimaldi M; Badagliacca R; Lanata L; Ricci RP J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441994 [TBL] [Abstract][Full Text] [Related]
3. Flecainide in clinical practice. Basza M; Maciejewski C; Bojanowicz W; Balsam P; Grabowski M; Mitkowski P; Kempa M; Kowalski O; Kalarus Z; Jaguszewski M; Lubiński A; Daniłowicz-Szymanowicz L; Szumowski Ł; Sterliński M; Kołtowski Ł Cardiol J; 2023; 30(3):473-482. PubMed ID: 36908162 [TBL] [Abstract][Full Text] [Related]
4. Flecainide acetate for the treatment of atrial and ventricular arrhythmias. Apostolakis S; Oeff M; Tebbe U; Fabritz L; Breithardt G; Kirchhof P Expert Opin Pharmacother; 2013 Feb; 14(3):347-57. PubMed ID: 23294160 [TBL] [Abstract][Full Text] [Related]
5. Safety of flecainide. Tamargo J; Capucci A; Mabo P Drug Saf; 2012 Apr; 35(4):273-89. PubMed ID: 22435343 [TBL] [Abstract][Full Text] [Related]
6. Flecainide: Electrophysiological properties, clinical indications, and practical aspects. Paolini E; Stronati G; Guerra F; Capucci A Pharmacol Res; 2019 Oct; 148():104443. PubMed ID: 31493514 [TBL] [Abstract][Full Text] [Related]
7. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group. Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395 [TBL] [Abstract][Full Text] [Related]
8. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis. Kukendrarajah K; Ahmad M; Carrington M; Ioannou A; Taylor J; Razvi Y; Papageorgiou N; Mead GE; Nevis IF; D'Ascenzo F; Wilton SB; Lambiase PD; Morillo CA; Kwong JS; Providencia R Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013255. PubMed ID: 38828867 [TBL] [Abstract][Full Text] [Related]
9. Proarrhythmic Effects Of Antiarrhythmic Drugs: Case Study Of Flecainide Induced Ventricular Arrhythmias During Treatment Of Atrial Fibrillation. Barman M J Atr Fibrillation; 2015 Dec; 8(4):1091. PubMed ID: 27957216 [TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Valembois L; Audureau E; Takeda A; Jarzebowski W; Belmin J; Lafuente-Lafuente C Cochrane Database Syst Rev; 2019 Sep; 9(9):CD005049. PubMed ID: 31483500 [TBL] [Abstract][Full Text] [Related]
11. Flecainide: Current status and perspectives in arrhythmia management. Andrikopoulos GK; Pastromas S; Tzeis S World J Cardiol; 2015 Feb; 7(2):76-85. PubMed ID: 25717355 [TBL] [Abstract][Full Text] [Related]
12. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial. Kirchhof P; Fetsch T; Hanrath P; Meinertz T; Steinbeck G; Lehmacher W; Breithardt G Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290956 [TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia. Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636 [TBL] [Abstract][Full Text] [Related]
14. Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia. Luedtke SA; Kuhn RJ; McCaffrey FM Ann Pharmacother; 1997 Nov; 31(11):1347-59. PubMed ID: 9391691 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of flecainide in patients with supraventricular arrhythmias and respiratory insufficiency. Barranco F; Sanchez M; Rodriguez J; Guerrero M Intensive Care Med; 1994; 20(1):42-4. PubMed ID: 8163757 [TBL] [Abstract][Full Text] [Related]
16. Medical cardioversion of atrial fibrillation and flutter with class IC antiarrhythmic drugs in young patients with and without congenital heart disease. Przybylski R; Eberly LM; Alexander ME; Bezzerides VJ; DeWitt ES; Dionne A; Mah DY; Triedman JK; Walsh EP; O'Leary ET J Cardiovasc Electrophysiol; 2023 Dec; 34(12):2545-2551. PubMed ID: 37846208 [TBL] [Abstract][Full Text] [Related]
17. Pharmacologic management of atrial fibrillation: established and emerging options. Kalus JS J Manag Care Pharm; 2009 Aug; 15(6 Suppl B):S10-8. PubMed ID: 19678722 [TBL] [Abstract][Full Text] [Related]